Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation

NCT02159248 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The study closed prior to enrolling any participants.

Conditions

Interventions

Sponsor

Orlando Health, Inc.